世界のシラミ治療市場2022年-2026年

【英語タイトル】Global Lice Treatment Market 2022-2026

Technavioが出版した調査資料(IRTNTR72486-22)・商品コード:IRTNTR72486-22
・発行会社(調査会社):Technavio
・発行日:2022年2月18日
・ページ数:約120
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:世界
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥350,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
テクナビオ社は、世界のシラミ治療市場規模が2022年から2026年まで年平均6.26%成長し、128.97百万ドルに達すると予測しています。本調査レポートは、シラミ治療の世界市場を調査対象とし、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、流通チャネル別(病院・クリニック、オンライン、小売薬局)分析、顧客状況、地域別状況、推進要因・課題・動向、企業状況、企業分析など、以下の項目をまとめております。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・世界のシラミ治療市場規模:流通チャネル別(病院・クリニック、オンライン、小売薬局)
・顧客状況
・地域別状況
・推進要因・課題・動向
・企業状況
・企業分析
❖ レポートの概要 ❖

Global Lice Treatment Market 2022-2026

Technavio has been monitoring the lice treatment market and it is poised to grow by $ 128.97 mn during 2022-2026, progressing at a CAGR of 6.26% during the forecast period. Our report on the lice treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of lice infestation, rising healthcare expenditure, and easy availability of lice treatment products. In addition, the increasing prevalence of lice infestation is anticipated to boost the growth of the market as well.

The lice treatment market analysis includes the distribution channel segment and geographic landscape.
Technavio’s lice treatment market is segmented as below:

By Distribution Channel
• Hospitals and clinics
• Online
• Retail pharmacies

By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing population of children as one of the prime reasons driving the lice treatment market growth during the next few years. Also, rising investments for R&D in targeted therapies and the emergence of novel treatment options will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on lice treatment market covers the following areas:
• Lice treatment market sizing
• Lice treatment market forecast
• Lice treatment market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lice treatment market vendors that include Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., and Bayer AG. Also, the lice treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/lice-treatment-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 06: Executive Summary – Chart on Incremental Growth
o Exhibit 07: Executive Summary – Data Table on Incremental Growth
o Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 09: Parent market
o Exhibit 10: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 11: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 12: Market segments
o 3.3 Market size 2021
o 3.4 Market outlook: Forecast for 2021-2026
o Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ million)
o Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
o Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• 4 Five Forces Analysis
o 4.1 Five forces summary
o Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
o 4.2 Bargaining power of buyers
o Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
o 4.3 Bargaining power of suppliers
o Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
o 4.4 Threat of new entrants
o Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
o 4.5 Threat of substitutes
o Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
o 4.6 Threat of rivalry
o Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
o 4.7 Market condition
o Exhibit 23: Chart on Market condition – Five forces 2021 and 2026
• 5 Market Segmentation by Distribution Channel
o 5.1 Market segments
o Exhibit 24: Chart on Distribution Channel – Market share 2021-2026 (%)
o Exhibit 25: Data Table on Distribution Channel – Market share 2021-2026 (%)
o 5.2 Comparison by Distribution Channel
o Exhibit 26: Chart on Comparison by Distribution Channel
o Exhibit 27: Data Table on Comparison by Distribution Channel
o 5.3 Hospitals and clinics – Market size and forecast 2021-2026
o Exhibit 28: Chart on Hospitals and clinics – Market size and forecast 2021-2026 ($ million)
o Exhibit 29: Data Table on Hospitals and clinics – Market size and forecast 2021-2026 ($ million)
o Exhibit 30: Chart on Hospitals and clinics – Year-over-year growth 2021-2026 (%)
o Exhibit 31: Data Table on Hospitals and clinics – Year-over-year growth 2021-2026 (%)
o 5.4 Online – Market size and forecast 2021-2026
o Exhibit 32: Chart on Online – Market size and forecast 2021-2026 ($ million)
o Exhibit 33: Data Table on Online – Market size and forecast 2021-2026 ($ million)
o Exhibit 34: Chart on Online – Year-over-year growth 2021-2026 (%)
o Exhibit 35: Data Table on Online – Year-over-year growth 2021-2026 (%)
o 5.5 Retail pharmacies – Market size and forecast 2021-2026
o Exhibit 36: Chart on Retail pharmacies – Market size and forecast 2021-2026 ($ million)
o Exhibit 37: Data Table on Retail pharmacies – Market size and forecast 2021-2026 ($ million)
o Exhibit 38: Chart on Retail pharmacies – Year-over-year growth 2021-2026 (%)
o Exhibit 39: Data Table on Retail pharmacies – Year-over-year growth 2021-2026 (%)
o 5.6 Market opportunity by Distribution Channel
o Exhibit 40: Market opportunity by Distribution Channel ($ million)
• 6 Customer Landscape
o 6.1 Customer landscape overview
o Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 7 Geographic Landscape
o 7.1 Geographic segmentation
o Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
o Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
o 7.2 Geographic comparison
o Exhibit 44: Chart on Geographic comparison
o Exhibit 45: Data Table on Geographic comparison
o 7.3 North America – Market size and forecast 2021-2026
o Exhibit 46: Chart on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 47: Data Table on North America – Market size and forecast 2021-2026 ($ million)
o Exhibit 48: Chart on North America – Year-over-year growth 2021-2026 (%)
o Exhibit 49: Data Table on North America – Year-over-year growth 2021-2026 (%)
o 7.4 Europe – Market size and forecast 2021-2026
o Exhibit 50: Chart on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 51: Data Table on Europe – Market size and forecast 2021-2026 ($ million)
o Exhibit 52: Chart on Europe – Year-over-year growth 2021-2026 (%)
o Exhibit 53: Data Table on Europe – Year-over-year growth 2021-2026 (%)
o 7.5 Asia – Market size and forecast 2021-2026
o Exhibit 54: Chart on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 55: Data Table on Asia – Market size and forecast 2021-2026 ($ million)
o Exhibit 56: Chart on Asia – Year-over-year growth 2021-2026 (%)
o Exhibit 57: Data Table on Asia – Year-over-year growth 2021-2026 (%)
o 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
o Exhibit 58: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 59: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ million)
o Exhibit 60: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o Exhibit 61: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
o 7.7 US – Market size and forecast 2021-2026
o Exhibit 62: Chart on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 63: Data Table on US – Market size and forecast 2021-2026 ($ million)
o Exhibit 64: Chart on US – Year-over-year growth 2021-2026 (%)
o Exhibit 65: Data Table on US – Year-over-year growth 2021-2026 (%)
o 7.8 UK – Market size and forecast 2021-2026
o Exhibit 66: Chart on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 67: Data Table on UK – Market size and forecast 2021-2026 ($ million)
o Exhibit 68: Chart on UK – Year-over-year growth 2021-2026 (%)
o Exhibit 69: Data Table on UK – Year-over-year growth 2021-2026 (%)
o 7.9 China – Market size and forecast 2021-2026
o Exhibit 70: Chart on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 71: Data Table on China – Market size and forecast 2021-2026 ($ million)
o Exhibit 72: Chart on China – Year-over-year growth 2021-2026 (%)
o Exhibit 73: Data Table on China – Year-over-year growth 2021-2026 (%)
o 7.10 Germany – Market size and forecast 2021-2026
o Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ million)
o Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
o Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
o 7.11 Japan – Market size and forecast 2021-2026
o Exhibit 78: Chart on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 79: Data Table on Japan – Market size and forecast 2021-2026 ($ million)
o Exhibit 80: Chart on Japan – Year-over-year growth 2021-2026 (%)
o Exhibit 81: Data Table on Japan – Year-over-year growth 2021-2026 (%)
o 7.12 Market opportunity By Geographical Landscape
o Exhibit 82: Market opportunity By Geographical Landscape ($ million)
• 8 Drivers, Challenges, and Trends
o 8.1 Market drivers
o 8.2 Market challenges
o 8.3 Impact of drivers and challenges
o Exhibit 83: Impact of drivers and challenges in 2021 and 2026
o 8.4 Market trends
• 9 Vendor Landscape
o 9.1 Overview
o 9.2 Vendor landscape
o Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
o 9.3 Landscape disruption
o Exhibit 85: Overview on factors of disruption
o 9.4 Industry risks
o Exhibit 86: Impact of key risks on business
• 10 Vendor Analysis
o 10.1 Vendors covered
o Exhibit 87: Vendors covered
o 10.2 Market positioning of vendors
o Exhibit 88: Matrix on vendor position and classification
o 10.3 Alliance Pharma Plc
o Exhibit 89: Alliance Pharma Plc – Overview
o Exhibit 90: Alliance Pharma Plc – Business segments
o Exhibit 91: Alliance Pharma Plc – Key offerings
o Exhibit 92: Alliance Pharma Plc – Segment focus
o 10.4 Arbor Pharmaceuticals LLC
o Exhibit 93: Arbor Pharmaceuticals LLC – Overview
o Exhibit 94: Arbor Pharmaceuticals LLC – Product / Service
o Exhibit 95: Arbor Pharmaceuticals LLC – Key offerings
o 10.5 Bayer AG
o Exhibit 96: Bayer AG – Overview
o Exhibit 97: Bayer AG – Business segments
o Exhibit 98: Bayer AG – Key news
o Exhibit 99: Bayer AG – Key offerings
o Exhibit 100: Bayer AG – Segment focus
o 10.6 Elanco Animal Health Inc.
o Exhibit 101: Elanco Animal Health Inc. – Overview
o Exhibit 102: Elanco Animal Health Inc. – Product / Service
o Exhibit 103: Elanco Animal Health Inc. – Key offerings
o 10.7 Fleming Medical Ltd.
o Exhibit 104: Fleming Medical Ltd. – Overview
o Exhibit 105: Fleming Medical Ltd. – Product / Service
o Exhibit 106: Fleming Medical Ltd. – Key offerings
o 10.8 Merck and Co. Inc.
o Exhibit 107: Merck and Co. Inc. – Overview
o Exhibit 108: Merck and Co. Inc. – Business segments
o Exhibit 109: Merck and Co. Inc. – Key news
o Exhibit 110: Merck and Co. Inc. – Key offerings
o Exhibit 111: Merck and Co. Inc. – Segment focus
o 10.9 PARAPRO LLC
o Exhibit 112: PARAPRO LLC – Overview
o Exhibit 113: PARAPRO LLC – Product / Service
o Exhibit 114: PARAPRO LLC – Key offerings
o 10.10 Prestige Consumer Healthcare Inc.
o Exhibit 115: Prestige Consumer Healthcare Inc. – Overview
o Exhibit 116: Prestige Consumer Healthcare Inc. – Business segments
o Exhibit 117: Prestige Consumer Healthcare Inc. – Key offerings
o Exhibit 118: Prestige Consumer Healthcare Inc. – Segment focus
o 10.11 Teva Pharmaceutical Industries Ltd.
o Exhibit 119: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 120: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 121: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 122: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 123: Teva Pharmaceutical Industries Ltd. – Segment focus
o 10.12 Thornton Ross Ltd.
o Exhibit 124: Thornton Ross Ltd. – Overview
o Exhibit 125: Thornton Ross Ltd. – Product / Service
o Exhibit 126: Thornton Ross Ltd. – Key offerings
• 11 Appendix
o 11.1 Scope of the report
o 11.2 Inclusions and exclusions checklist
o Exhibit 127: Inclusions checklist
o Exhibit 128: Exclusions checklist
o 11.3 Currency conversion rates for US$
o Exhibit 129: Currency conversion rates for US$
o 11.4 Research methodology
o Exhibit 130: Research methodology
o Exhibit 131: Validation techniques employed for market sizing
o Exhibit 132: Information sources
o 11.5 List of abbreviations
o Exhibit 133: List of abbreviations



❖ 掲載企業 ❖

Alliance Pharma Plc, American Vanguard Corp., Arbor Pharmaceuticals LLC, Elanco Animal Health Inc., Fleming Medical Ltd., Johnson and Johnson Inc., Logic Product Group LLC, Marico Ltd., Merck and Co. Inc., Nix Pharma Pvt Ltd., PARAPRO LLC, Perrigo Co. Plc, Prestige Consumer Healthcare Inc., SHIONOGI Co. Ltd., TecLabs Inc., Teva Pharmaceutical Industries Ltd., Thornton & Ross Ltd., Bayer AG

★調査レポート[世界のシラミ治療市場2022年-2026年] (コード:IRTNTR72486-22)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のシラミ治療市場2022年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆